171 related articles for article (PubMed ID: 17318307)
1. Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats.
Paulson L; Martin P; Ljung E; Blennow K; Davidsson P
J Neural Transm (Vienna); 2007 Jul; 114(7):885-91. PubMed ID: 17318307
[TBL] [Abstract][Full Text] [Related]
2. NMDA glutamate receptor antagonist MK-801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine.
de Almeida V; Mendes ND; Zuccoli GS; Reis-de-Oliveira G; Almeida GM; Podolsky-Gondim GG; Neder L; Martins-de-Souza D; Sebollela A
J Neurochem; 2024 Mar; 168(3):238-250. PubMed ID: 38332572
[TBL] [Abstract][Full Text] [Related]
3. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.
López-Gil X; Babot Z; Amargós-Bosch M; Suñol C; Artigas F; Adell A
Neuropsychopharmacology; 2007 Oct; 32(10):2087-97. PubMed ID: 17356574
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC.
Baviera M; Invernizzi RW; Carli M
Psychopharmacology (Berl); 2008 Feb; 196(2):269-80. PubMed ID: 17940750
[TBL] [Abstract][Full Text] [Related]
6. Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats.
Paine TA; Carlezon WA
Neuropharmacology; 2009 Mar; 56(4):788-97. PubMed ID: 19705572
[TBL] [Abstract][Full Text] [Related]
7. Effects on rat thalamic proteome by acute and subchronic MK-801-treatment.
Paulson L; Martin P; Ljung E; Blennow K; Davidsson P
Eur J Pharmacol; 2004 Nov; 505(1-3):103-9. PubMed ID: 15556142
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
[TBL] [Abstract][Full Text] [Related]
9. A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat.
Lim AL; Taylor DA; Malone DT
J Psychopharmacol; 2012 Sep; 26(9):1252-64. PubMed ID: 22361477
[TBL] [Abstract][Full Text] [Related]
10. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
11. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.
Hoffman DC; Donovan H; Cassella JV
Psychopharmacology (Berl); 1993; 111(3):339-44. PubMed ID: 7870972
[TBL] [Abstract][Full Text] [Related]
12. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice.
Ozdemir H; Ertugrul A; Basar K; Saka E
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):62-8. PubMed ID: 22640753
[TBL] [Abstract][Full Text] [Related]
14. Clozapine Improves Behavioral and Biochemical Outcomes in a MK-801-Induced Mouse Model of Schizophrenia.
Andrabi SS; Vishnoi S; Madan R; Bhardwaj N; Tabassum H; Akram M; Parvez S
J Environ Pathol Toxicol Oncol; 2020; 39(1):1-12. PubMed ID: 32479008
[TBL] [Abstract][Full Text] [Related]
15. Altered 13C glucose metabolism in the cortico-striato-thalamo-cortical loop in the MK-801 rat model of schizophrenia.
Eyjolfsson EM; Nilsen LH; Kondziella D; Brenner E; Håberg A; Sonnewald U
J Cereb Blood Flow Metab; 2011 Mar; 31(3):976-85. PubMed ID: 21081956
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits.
Schmitt A; Zink M; Müller B; May B; Herb A; Jatzko A; Braus DF; Henn FA
Neurochem Res; 2003 Feb; 28(2):235-41. PubMed ID: 12608697
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.
Rezvani AH; Tizabi Y; Getachew B; Hauser SR; Caldwell DP; Hunter C; Levin ED
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1030-40. PubMed ID: 18343006
[TBL] [Abstract][Full Text] [Related]
18. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses.
Meshul CK; Bunker GL; Mason JN; Allen C; Janowsky A
J Neurochem; 1996 Nov; 67(5):1965-73. PubMed ID: 8863502
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.
Zink M; Schmitt A; May B; Müller B; Demirakca T; Braus DF; Henn FA
Schizophr Res; 2004 Feb; 66(2-3):151-7. PubMed ID: 15061247
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
